SCHEMBL30678682

SCHEMBL30678682

O=C(Oc1nncs1)N1CCCCC1

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.50
POLB P06746 1/20 0.50
MEN1 O00255 5/20 0.44
KMT2A Q03164 5/20 0.44
HSD17B10 Q99714 1/20 0.44
LIPA P38571 4/20 0.43
SMN1; SMN2 Q16637 5/20 0.43
MAPT P10636 3/20 0.43
HTT P42858 2/20 0.43
NPSR1 Q6W5P4 3/20 0.42
LMNA P02545 2/20 0.42
GAA P10253 1/20 0.41
NPC1 O15118 3/20 0.41
TSHR P16473 3/20 0.41
RAB9A P51151 2/20 0.41
TDP1 Q9NUW8 2/20 0.39
ATM Q13315 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
HRH3 Q9Y5N1 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31111632 0.75 ALDH1A1 (0.51) ALDH1A1POLBMEN1KMT2AHSD17B10
SCHEMBL2050164 0.75 ALDH1A1 (0.51) ALDH1A1POLBMEN1KMT2AHSD17B10
SCHEMBL30515023 0.71 ALDH1A1 (0.50) ALDH1A1POLBMEN1KMT2AHSD17B10
SCHEMBL30473912 0.69 ALDH1A1 (0.56) ALDH1A1POLBMEN1KMT2AHSD17B10
SCHEMBL28673249 0.69 KMT2A (0.62) ALDH1A1POLBMEN1KMT2AHSD17B10
SCHEMBL28558035 0.69 SMN1; SMN2 (0.49) ALDH1A1POLBMEN1KMT2ALIPA
SCHEMBL22978700 0.66 ALDH1A1 (0.47) ALDH1A1POLBMEN1KMT2AHSD17B10
SCHEMBL31629008 0.66 ALDH1A1 (0.51) ALDH1A1POLBMEN1KMT2AHSD17B10
SCHEMBL31127701 0.66 ALDH1A1 (0.51) ALDH1A1POLBMEN1KMT2AHSD17B10
SCHEMBL31589528 0.65 ALDH1A1 (0.50) ALDH1A1POLBMEN1KMT2AHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117157298-A Dual-function chimeric heterocyclic compound of interleukin-1 receptor related kinase 4, preparation method, medicinal composition and application thereof 石药集团中奇制药技术(石家庄)有限公司 2023-12-01 CN disclosed